The NEC lawsuit has not reached a global settlement yet, but 2026 is shaping up to be one of the most decisive years in this litigation. Thousands of families who lost premature babies or watched them suffer permanent injuries after being fed cow’s milk-based hospital formula are waiting for answers, and some are closer to getting them than others.
The litigation involves two of the biggest names in baby formula: Abbott Laboratories, maker of Similac, and Mead Johnson, maker of Enfamil. Both companies face claims that their products caused necrotizing enterocolitis, a devastating intestinal disease, in premature infants.
This article breaks down everything you need to know about the NEC lawsuit in 2026. You’ll find out who qualifies, what payouts might look like, how the federal court process is unfolding, and what the realistic timeline is for families to receive compensation.
When Will the NEC Lawsuit Be Settled?
No confirmed global settlement date exists for the NEC lawsuit as of 2026, but the litigation is moving toward resolution faster than at any previous point.
The cases are currently consolidated in federal court as a mass tort MDL. Bellwether trials, which are test cases designed to show both sides what juries think, have been producing verdicts that push defendants toward settlement conversations.
In mass tort litigation like this, global settlements typically happen after multiple jury verdicts make it financially smarter for companies to pay than to keep fighting. The NEC litigation is approaching that point.
| Status Detail | Current Information |
|---|---|
| Global Settlement Reached | Not yet as of 2026 |
| Settlement Talks Active | Yes, ongoing |
| Key Driver | Bellwether trial verdicts |
| Expected Resolution Window | 2026 to 2028 (depending on defendant) |
Individual cases can still settle privately before any global deal. Many already have, under confidential terms.
NEC Baby Formula Lawsuit Settlement 2026: Where Things Stand
The NEC baby formula lawsuit settlement picture in 2026 is split: some families have already settled privately, while the larger group is still waiting for the MDL process to produce a global deal.
This is common in mass tort litigation. Companies often settle the strongest cases first, quietly and confidentially, while continuing to fight the rest. It reduces their exposure without triggering a massive public payout.
The MDL judge overseeing the federal cases has been pushing both sides toward resolution. Increased trial scheduling pressure in 2026 is expected to accelerate settlement discussions significantly.
Key point: A global settlement is not the same as a class action settlement. Each family in the NEC litigation will likely negotiate their own individual compensation amount based on the severity of their case.
| Settlement Type | What It Means for Families |
|---|---|
| Individual Private Settlement | Negotiated directly; often faster; amount is confidential |
| Global MDL Settlement | Applies to all remaining plaintiffs; structured payout system |
| Trial Verdict | Jury decides compensation; subject to appeal |
What Is the NEC Baby Formula Lawsuit About?
The NEC baby formula lawsuit is about one central claim: that cow’s milk-based formulas sold specifically for premature infants significantly increase the risk of necrotizing enterocolitis, a life-threatening bowel disease.
Necrotizing enterocolitis, or NEC, causes intestinal tissue to die. In premature babies, whose immune systems are already fragile, NEC can be fatal. Survivors often face lifelong complications including intestinal failure and developmental problems.
Plaintiffs argue that Abbott and Mead Johnson knew about the elevated NEC risk in premature infants for years. They allege the companies failed to warn hospitals and parents about that risk while continuing to market their products aggressively to NICUs.
The scientific foundation for these claims is strong. Research published in peer-reviewed journals has consistently shown that premature infants fed cow’s milk-based formula face a significantly higher NEC risk compared to those fed human breast milk.
| Key Facts | Details |
|---|---|
| Disease at Issue | Necrotizing Enterocolitis (NEC) |
| Products Named | Similac Special Care, Enfamil Premature |
| Defendants | Abbott Laboratories, Mead Johnson (Reckitt) |
| Core Allegation | Failure to warn about elevated NEC risk in preterm infants |
NEC Lawsuit Update 2026: Latest Court Developments
The most significant NEC lawsuit update for 2026 is that trial activity has intensified and both defendants are under growing legal pressure to resolve claims.
After years of preliminary legal battles, the federal MDL in the Northern District of Illinois has moved into a more aggressive trial phase. State court cases in Illinois, Missouri, and other jurisdictions have produced mixed but notable verdicts, giving both sides real data to work with.
Courts have rejected several attempts by Abbott and Mead Johnson to get cases dismissed on federal preemption grounds. That was a major blow to the defense, clearing the way for more trials to proceed.
2026 developments to watch:
- Additional bellwether trials scheduled in federal MDL
- State court trials continuing in Illinois and Missouri
- Defense appeals of prior verdicts still working through courts
- Increasing plaintiff filings as awareness grows
The litigation ecosystem is large and active. New cases are still being filed in 2026, which tells you the window to join is not closed.
Key Takeaway: The NEC lawsuit is deeper into trial territory in 2026 than ever before, and that pressure is what drives companies toward global settlements.
NEC Lawsuit Trial Verdicts From 2025 and 2026
Several significant jury verdicts have already been returned in NEC cases, and they are reshaping how both sides approach settlement.
In 2022, a St. Louis jury returned a verdict of approximately $495 million against Mead Johnson in a single NEC case. While that verdict was appealed and is subject to legal review, its size sent a clear message to defendants about jury sentiment.
Illinois state court trials have produced additional plaintiff-friendly results. These verdicts matter because they function like a preview of what a global settlement negotiation has to reckon with.
| Verdict | Amount | Defendant | Court | Year |
|---|---|---|---|---|
| Missouri State Trial | ~$495 million | Mead Johnson | St. Louis Circuit Court | 2022 |
| Illinois State Trial | Confidential | Abbott | Cook County | 2023 |
| Bellwether MDL Trials | Ongoing | Both defendants | N.D. Illinois | 2025-2026 |
Not every verdict has favored plaintiffs. Some cases have been dismissed or returned defense verdicts. That mixed record is actually normal in mass tort litigation and does not indicate weakness in the overall case.
NEC Lawsuit MDL Status 2026: What the Federal Court Is Doing
MDL 3026, the federal consolidated litigation for NEC baby formula cases, is pending in the Northern District of Illinois. This is where the majority of federal NEC claims are centralized.
An MDL, or multidistrict litigation, is not a class action. It groups similar lawsuits together for pretrial coordination so every plaintiff doesn’t have to independently conduct the same discovery process. Each family’s case remains individual.
The MDL judge has been scheduling bellwether trials to test how juries respond to the scientific and legal arguments on both sides. Results from those trials directly influence settlement negotiations.
What the MDL process looks like in 2026:
- Pretrial discovery is largely complete for early filed cases
- Bellwether trial schedule is active
- Defense motions to exclude expert testimony have been largely denied
- Plaintiff expert evidence on NEC causation is before the court
Think of the MDL like a pressure cooker. The longer trials go on and the more verdicts stack up, the more pressure builds on defendants to offer a global settlement. That pressure is at a historically high level in 2026.
Abbott NEC Lawsuit Settlement Update
Abbott Laboratories, maker of Similac Special Care and other premature infant formulas, has not agreed to a global settlement as of 2026.
Abbott has taken an aggressive litigation posture. The company has argued in court that its products are not defective and that NEC in premature infants has multiple potential causes. Abbott has also attempted, unsuccessfully in most courts, to argue that federal regulations preempt state tort claims.
Despite that posture, Abbott has reportedly settled individual cases on confidential terms. This is standard practice: quietly resolve the most dangerous cases while publicly maintaining that no liability exists.
Abbott NEC lawsuit status summary:
- No confirmed global settlement
- Individual confidential settlements reported
- Federal preemption defense largely rejected by courts
- Ongoing trial exposure in MDL and state courts
- Stock price and investor pressure are increasing
Abbott’s legal exposure grew substantially after the Illinois Supreme Court allowed cases against them to proceed. That ruling removed one of their most powerful defense tools.
Key Takeaway: Abbott has not settled globally, but individual families have received compensation. The company’s continued trial losses increase the likelihood of a broader resolution in 2026 or 2027.
Mead Johnson NEC Lawsuit Settlement Status
Mead Johnson Nutrition, owned by Reckitt Benckiser, is the defendant behind Enfamil Premature formula and faces its own massive wave of NEC claims.
The $495 million Missouri verdict in 2022 hit Mead Johnson hardest of all the defendants in terms of public trial exposure. That verdict, though appealed, became a defining moment in this litigation. It showed what juries are capable of awarding.
Mead Johnson has also contested liability aggressively. Reckitt, as the parent company, has taken the financial hit in its earnings reports, disclosing significant legal reserve increases related to NEC litigation.
| Mead Johnson Status | Detail |
|---|---|
| Parent Company | Reckitt Benckiser |
| Formula Involved | Enfamil Premature, Enfamil Human Milk Fortifier |
| Largest Known Verdict | ~$495 million (2022, under appeal) |
| Global Settlement | Not reached as of 2026 |
| Settlement Talks | Ongoing, according to court filings |
The appeal of the Missouri verdict has been closely watched. Regardless of the appeals outcome, the underlying message to Mead Johnson from juries has been clear.
Who Qualifies for the NEC Lawsuit?
You may qualify for the NEC lawsuit if your premature infant developed necrotizing enterocolitis after being fed cow’s milk-based formula in a hospital NICU setting.
Both Abbott and Mead Johnson formulas are named in current litigation. The key factors that determine eligibility are the infant’s prematurity at birth, whether they were fed a qualifying formula, and whether they received an NEC diagnosis.
Basic qualification factors:
- Infant was born prematurely (generally before 37 weeks gestation)
- Infant was fed Similac and/or Enfamil premature formula in a hospital
- Infant was diagnosed with NEC
- Diagnosis resulted in injury, surgery, permanent disability, or death
The diagnosis does not need to be recent. Cases where NEC occurred years ago may still qualify depending on state statute of limitations rules. Many families who never considered filing are still eligible.
Key Takeaway: Premature birth, hospital formula feeding, and an NEC diagnosis are the three core qualifiers. If those three elements are present, a claim is worth investigating.
NEC Baby Formula Lawsuit Eligibility Requirements Explained
Eligibility for the NEC lawsuit comes down to specific medical and factual criteria that attorneys use to evaluate each case.
Not every premature infant who developed NEC automatically has a viable claim. The connection between the formula and the diagnosis has to be documentable. That’s why medical records from the NICU stay are essential.
Detailed eligibility requirements:
| Requirement | Specifics |
|---|---|
| Prematurity | Born before 37 weeks gestation |
| Formula Type | Cow’s milk-based: Similac Special Care, Enfamil Premature, or similar |
| Administration | Fed formula in hospital, typically in NICU |
| Diagnosis | Confirmed NEC diagnosis in medical records |
| Outcome | Injury requiring surgery, long-term disability, or death |
| Statute of Limitations | Varies by state; typically 2 to 3 years from discovery of harm |
The “discovery rule” is important here. In many states, the statute of limitations clock starts when you knew or reasonably should have known that the formula caused the injury, not necessarily when the injury happened.
Families whose babies were injured several years ago may still have time to file. Talking to an attorney who handles NEC cases is the fastest way to know for certain where you stand.
NEC Lawsuit Settlement Amount Per Person
The NEC lawsuit settlement amount per person varies widely and depends on the severity of the child’s injury, the strength of the evidence, and which defendant is involved.
There is no announced global settlement payout grid yet. Individual cases that have settled privately have done so under confidential non-disclosure agreements, so exact numbers are not public.
However, trial verdicts give us a meaningful reference point. Jury awards in individual NEC trials have ranged from the millions into the hundreds of millions, though most real-world settlements land far below the headline verdict numbers.
Estimated settlement ranges based on available data:
| Injury Severity | Estimated Settlement Range |
|---|---|
| NEC with survival and full recovery | $500,000 to $2 million |
| NEC with permanent disability or intestinal damage | $2 million to $10 million |
| NEC resulting in wrongful death | $5 million to $20 million or more |
| Cases with exceptional facts or egregious conduct | Potentially higher |
These are estimates informed by similar mass tort settlement patterns and reported verdicts. Every case is different, and attorneys negotiate individual amounts based on specific facts.
How Much Will the NEC Lawsuit Pay Out?
The NEC lawsuit could pay out billions of dollars in total across all plaintiffs, though the per-family amount depends entirely on the specifics of each case.
Looking at comparable pharmaceutical and baby product mass torts gives useful context. Johnson and Johnson’s talc litigation resulted in settlements exceeding $8 billion. Roundup cancer litigation topped $10 billion in global settlements. NEC litigation involves comparable corporate conduct and severity of harm.
Total financial exposure for Abbott and Mead Johnson combined is estimated in the tens of billions when you factor in all pending and potential claims. That scale of exposure is what historically forces global settlements.
Why the total matters for individual families:
When defendants face truly massive aggregate liability, they have a financial incentive to structure global settlements that provide certainty. A global deal caps their exposure. In exchange, plaintiffs receive faster, guaranteed payments rather than waiting years for individual trials.
The more verdicts that come in, the higher the floor on what any global settlement must offer. That dynamic benefits families who are still waiting.
NEC Premature Baby Lawsuit Payout: Real Numbers From Verdicts
Real verdict numbers from NEC trials give the most concrete picture of what courts believe these cases are worth.
The 2022 Missouri verdict awarded approximately $495 million to the family of a premature infant who died from NEC after being fed Enfamil. That verdict remains the largest known in NEC litigation.
A 2023 Illinois trial also returned a plaintiff verdict, though the amount was not publicly disclosed. Multiple smaller verdicts in the range of several million dollars have been returned in state courts.
Verdicts and reported outcomes:
| Case Location | Outcome | Approximate Amount | Defendant |
|---|---|---|---|
| St. Louis, Missouri (2022) | Plaintiff verdict | ~$495 million | Mead Johnson |
| Cook County, Illinois (2023) | Plaintiff verdict | Undisclosed | Abbott |
| St. Louis, Missouri (2023) | Defense verdict | N/A | Abbott |
| MDL Bellwether (2025-2026) | Pending results | TBD | Both |
The defense verdict in one Missouri case is a reminder that not every trial goes to the plaintiff. That’s why strong medical records and expert testimony matter so much to each individual case’s value.
Key Takeaway: Verdicts in NEC cases have ranged from zero to nearly half a billion dollars, which means the strength of your individual case documentation has a direct impact on potential compensation.
NEC Lawsuit Statute of Limitations: Don’t Miss This Deadline
The NEC lawsuit statute of limitations is one of the most important deadlines in this litigation, and missing it permanently bars your family from filing a claim.
Each state sets its own statute of limitations for product liability cases. Most states allow between 2 and 3 years to file. The clock typically starts when the injury occurred or when you reasonably discovered the connection between the formula and the NEC diagnosis.
State-by-state overview (general ranges):
| State | General Statute of Limitations | Notes |
|---|---|---|
| Illinois | 2 years | Runs from discovery of harm |
| Missouri | 5 years | Products liability |
| California | 2 years | Personal injury standard |
| Texas | 2 years | From date of injury or discovery |
| New York | 3 years | Products liability |
| Florida | 2 years (changed 2023) | Check current law |
If your child’s NEC diagnosis happened several years ago, you may still have time under the discovery rule. Courts have allowed claims where parents only recently connected the formula to the NEC diagnosis.
Do not wait. The statute of limitations is a hard legal deadline. There is no exception once it passes.
How to File a NEC Lawsuit Claim in 2026
Filing a NEC lawsuit claim in 2026 starts with gathering your child’s medical records and connecting with an attorney who handles NEC cases.
You do not file directly with the MDL court yourself. NEC cases are filed by plaintiff attorneys who then coordinate with the MDL or state court systems depending on your jurisdiction.
Step-by-step claim process:
- Gather all NICU and hospital records showing the NEC diagnosis and formula feeding history
- Collect birth records showing gestational age at birth
- Document all long-term medical treatments related to NEC
- Contact an attorney who specializes in NEC or baby formula litigation
- Complete a case intake evaluation (usually free)
- Attorney files your lawsuit in appropriate court
- Case joins MDL or proceeds in state court
Most NEC attorneys work on contingency. That means you pay nothing upfront. They collect a percentage only if you win or settle.
What to have ready:
- NICU discharge summary
- NEC diagnosis documentation
- Surgical records if applicable
- Records showing which formula was used
- Any photos or personal records from the hospital stay
NEC Lawsuit Timeline: From Filing to Settlement
The NEC lawsuit timeline varies significantly depending on whether your case settles early, goes through the MDL process, or proceeds to individual trial.
Mass tort litigation moves slowly by design. The MDL process exists to handle thousands of cases efficiently, but that efficiency takes time to work through.
Realistic NEC lawsuit timeline:
| Phase | Typical Duration |
|---|---|
| Case intake and investigation | 1 to 3 months |
| Filing lawsuit | Within 30 days of retainer |
| MDL pretrial coordination | 1 to 2 years |
| Bellwether trials | Ongoing 2025 to 2026 |
| Global settlement negotiation | Likely 2026 to 2028 |
| Individual payout after global deal | 6 to 18 months after settlement |
| Total time from filing to payment | 2 to 5 years (varies widely) |
Families who file now are joining a litigation that has already done most of its foundational work. Discovery is largely complete. Expert testimony has been vetted by courts. The bellwether trial process is underway.
That matters because earlier phases are the slowest. New clients entering the MDL in 2026 benefit from years of prior litigation groundwork.
Is the NEC Lawsuit Still Open in 2026?
Yes, the NEC lawsuit is absolutely still open in 2026, and new cases are still being accepted.
No global settlement has closed the litigation. The MDL remains active. State court cases continue to be filed and tried. Both Abbott and Mead Johnson are still named as defendants with unresolved claims.
For families who have not yet filed, 2026 is not too late, but the window is not permanent. Statutes of limitations will eventually bar claims that are not timely filed.
Signs the litigation is still very much active:
- New bellwether trials scheduled throughout 2026
- Both defendants are actively fighting cases in court
- Plaintiff attorneys are still accepting new NEC clients
- Courts continue to rule on evidence and expert witness disputes
- No settlement administration process has been announced
If your family was affected by NEC following premature formula feeding and you have not spoken to an attorney, 2026 is the time to act. The litigation infrastructure is built, the evidence is well-established, and families are beginning to see results.
Frequently Asked Questions
When will NEC lawsuit settlements be paid out?
NEC lawsuit settlements are not expected to be paid out in bulk until a global settlement is negotiated, which attorneys estimate could occur between 2026 and 2028.
Individual families who have already settled privately received their payments under confidential terms.
Families still waiting should expect that a global deal, when it comes, will include a payment structure that may take an additional 6 to 18 months to distribute.
How much money can I get from the NEC baby formula lawsuit?
The amount varies significantly based on injury severity, from hundreds of thousands of dollars for less severe cases to tens of millions for wrongful death claims.
Jury verdicts in comparable cases have reached nearly $500 million, though real-world settlements are typically structured lower.
Your attorney will evaluate the specific facts of your case to give you a more accurate projection.
Do I still qualify to file a NEC lawsuit claim in 2026?
You may still qualify in 2026 if your child’s NEC diagnosis occurred within your state’s statute of limitations window.
Many states allow 2 to 5 years from the date of injury or from when you discovered the connection between the formula and the diagnosis.
Speaking with a NEC plaintiff attorney is the fastest way to confirm whether your case is still within the filing window.
What is the difference between the Abbott and Mead Johnson NEC lawsuits?
Abbott and Mead Johnson are separate defendants facing separate lawsuits, though both are consolidated in the same federal MDL.
Abbott makes Similac Special Care and is the larger company; Mead Johnson, owned by Reckitt, makes Enfamil Premature and has faced the largest single jury verdict so far.
Settlement negotiations with each defendant are happening independently, which means one company could reach a global deal before the other.
How long does the NEC baby formula lawsuit take to settle?
The full NEC baby formula litigation could take until 2028 or beyond to fully resolve for all plaintiffs.
Individual cases that settle privately can resolve much faster, sometimes within 1 to 2 years of filing.
Families who file now benefit from the years of MDL groundwork already completed, which shortens the pretrial phase considerably.
The litigation is real, the verdicts are in, and families are beginning to get results.
The NEC lawsuit is not a future event. It’s happening right now in federal and state courts, and 2026 is one of the most active years in its history.
If your premature infant developed NEC after being fed hospital formula, your window to file a claim is open but not permanent.
Gather your medical records, contact a NEC plaintiff attorney, and get a free case evaluation. The groundwork has been laid. The only question is whether your family is part of the resolution.
